Mark James Daniel insider trades
Open-market stock purchases and sales by Mark James Daniel, Chief Financial Officer at Atossa Therapeutics, Inc, from SEC Form 4 filings since Oct 14, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 26, 2026 | ATOS Atossa Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ATOS Atossa Therapeutics, Inc: other filings, last Mar 26, 2026